Associated Papers
How can we use stem cell-derived cardiomyocytes to understand the involvement of energetic metabolism in alterations of cardiac function?
Rebs S et al.
Frontiers in Molecular Medicine, 2023
Recent Advances in Modeling Mitochondrial Cardiomyopathy Using Human Induced Pluripotent Stem Cells.
Pavez-Giani MG et al.
Frontiers in Cell and Developmental Biology, 2021
Role of Tafazzin in Mitochondrial Function, Development and Disease.
Chin MT et al.
Journal of Developmental Biology, 2020
Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A et al.
International Journal of Molecular Sciences, 2019
Dilated Cardiomyopathy in a 2-Year-Old Infant.
Peake RW et al.
Clinical Chemistry, 2017
Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain.
Hijikata A et al.
Meta Gene, 2015
Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies.
Saric A et al.
Frontiers in Genetics, 2015
Your heart on a chip: iPSC-based modeling of Barth-syndrome-associated cardiomyopathy.
Zweigerdt R et al.
Cell Stem Cell, 2014
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.
Wang G et al.
Nature Medicine, 2014
Select a paper to view details